203 related articles for article (PubMed ID: 36432189)
1. Phenotypic Evaluation of Nucleoside Analogues against
Fiuza LFA; Batista DGJ; Girão RD; Hulpia F; Finamore-Araújo P; Aldfer MM; Elmahallawy EK; De Koning HP; Moreira O; Van Calenbergh S; Soeiro MNC
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432189
[TBL] [Abstract][Full Text] [Related]
2. N
Lin C; Jaén Batista DDG; Mazzeti AL; Donola Girão R; de Oliveira GM; Karalic I; Hulpia F; Soeiro MNC; Maes L; Caljon G; Van Calenbergh S
Eur J Med Chem; 2022 Mar; 231():114165. PubMed ID: 35144125
[TBL] [Abstract][Full Text] [Related]
3. The
Aldfer MM; Alfayez IA; Elati HAA; Gayen N; Elmahallawy EK; Milena Murillo A; Marsiccobetre S; Van Calenbergh S; Silber AM; de Koning HP
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432150
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Pyrrolo[2,3-
Lin C; Hulpia F; da Silva CF; Batista DDGJ; Van Hecke K; Maes L; Caljon G; Soeiro MNC; Van Calenbergh S
J Med Chem; 2019 Oct; 62(19):8847-8865. PubMed ID: 31495177
[No Abstract] [Full Text] [Related]
5. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S
Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877
[TBL] [Abstract][Full Text] [Related]
6. Revisiting Pyrazolo[3,4-
Bouton J; Ferreira de Almeida Fiuza L; Cardoso Santos C; Mazzarella MA; Soeiro MNC; Maes L; Karalic I; Caljon G; Van Calenbergh S
J Med Chem; 2021 Apr; 64(7):4206-4238. PubMed ID: 33784107
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi.
De Araújo JS; Da Silva CF; Batista DG; Da Silva PB; Meuser MB; Aiub CA; da Silva MF; Araújo-Lima CF; Banerjee M; Farahat AA; Stephens CE; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2014 Jul; 58(7):4191-5. PubMed ID: 24590476
[TBL] [Abstract][Full Text] [Related]
9.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
10. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
12. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
13. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel 7-Aryl 7-Deazapurine 3'-Deoxy-ribofuranosyl Nucleosides with Potent Activity against Trypanosoma cruzi.
Hulpia F; Van Hecke K; França da Silva C; da Gama Jaen Batista D; Maes L; Caljon G; de Nazaré C Soeiro M; Van Calenbergh S
J Med Chem; 2018 Oct; 61(20):9287-9300. PubMed ID: 30234983
[TBL] [Abstract][Full Text] [Related]
15. 6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy.
Lin C; Ferreira de Almeida Fiuza L; Cardoso Santos C; Ferreira Nunes D; Cruz Moreira O; Bouton J; Karalic I; Maes L; Caljon G; Hulpia F; de Nazaré C Soeiro M; Van Calenbergh S
ChemMedChem; 2021 Jul; 16(14):2231-2253. PubMed ID: 33856742
[TBL] [Abstract][Full Text] [Related]
16. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
17. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
20. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
